Skip to main content
Equibles

IBT-B · Infant Bacterial Therapeutics AB · Insider Trading

Use IBT-B with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IBT-B.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
72.9000 SEK -1.3000 (-1.75%) At close · Oct 8
Rebalance outlook locked
Market Cap
999.58M SEK
Shares
13.47M

Transactions in Infant Bacterial Therapeutics AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.

Director and related-person transactions

Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.

Source-reported transactions from Finansinspektionen, Sweden
Transaction datePersonTransactionInstrumentVolumePriceStatus
2026-09-10 Staffan Strömberg Chief Executive Officer (CEO)/Managing Directory Allotment Infant Bacterial Therapeutics AB ser. B Option · SE0008015259 65000 Quantity 0 SEK Current
2026-09-10 Anders Kronström Other senior executive Allotment Personaloptionsprogram 2026/2029 Option · 32500 Quantity 0 SEK Current
2025-09-25 Anders Kronström Other senior executive Allotment Personaloptionsprogram 2025/2028 Option · 32500 Quantity 0 SEK Current
2025-09-25 Maria Ekdahl Chief Financial Officer (CFO) Allotment Personaloptionsprogram 2025/2028 Option · 32500 Quantity 0 SEK Current
2025-09-25 Staffan Strömberg Chief Executive Officer (CEO)/Managing Directory Allotment Personal optionsprogram 25/28 Option · 65000 Quantity 0 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 76 Quantity 60.6 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 82 Quantity 60.8 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 81 Quantity 61 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 81 Quantity 61.2 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 524 Quantity 61.2 SEK Current
2025-05-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 511 Quantity 61.4 SEK Current
2024-11-14 Maria Ekdahl Chief Financial Officer (CFO) · Related person: Yes Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 500 Quantity 34 SEK Current
2024-09-02 Maria Ekdahl Chief Financial Officer (CFO) · Related person: Yes Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 1000 Quantity 25.5 SEK Current
2024-09-02 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 11000 Quantity 25 SEK Current
2024-09-02 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 3000 Quantity 25 SEK Current
2024-05-28 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB Option 2024/2027 Subcription warrant · 25000 Quantity 12.2 SEK Current ändrat från teckning till förvärv
2024-05-28 Anders Kronström Other senior executive Acquisition Infant Bacterial Therapeutics AB Option 2024/2027 Subcription warrant · 25000 Quantity 12.2 SEK Current
2024-05-28 Staffan Strömberg Chief Executive Officer (CEO)/Managing Directory Acquisition Infant Bacterial Therapeutics AB ser. B Option · 50000 Quantity 12.2 SEK Current
2024-05-28 Maria Ekdahl Chief Financial Officer (CFO) Subscription Infant Bacterial Therapeutics AB Option 2024/2027 Subcription warrant · 25000 Quantity 12.2 SEK Revised
2024-05-28 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 4 Quantity 96 SEK Current
2024-05-28 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 152 Quantity 95.8 SEK Current
2024-05-17 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 37 Quantity 96.2 SEK Current
2024-05-17 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 88 Quantity 96.8 SEK Current
2024-05-17 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 56 Quantity 97.2 SEK Current
2024-05-17 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 89 Quantity 97.6 SEK Current
2024-05-10 Eva Idén Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 200 Quantity 89.8 SEK Current
2024-05-13 Margareta Hagman Member of the Board of Directors Acquisition IBT B Infant Bacterial Therapeutics Share · SE0010713958 1000 Quantity 93.4098 SEK Current
2024-05-10 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 1250 Quantity 90 SEK Current
2024-05-10 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 178 Quantity 89 SEK Current
2024-05-10 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 128 Quantity 90 SEK Current
2024-05-10 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 894 Quantity 92 SEK Current
2024-03-04 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 38 Quantity 79.8 SEK Current
2024-03-04 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 422 Quantity 80 SEK Current
2024-02-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 839 Quantity 94.2 SEK Current
2024-02-08 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 161 Quantity 94 SEK Current
2023-12-28 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 245 Quantity 90.8 SEK Current
2023-12-13 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 350 Quantity 86 SEK Current
2023-12-13 Anthon Jahreskog Member of the Board of Directors Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 700 Quantity 86.2 SEK Current
2023-11-22 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 442 Quantity 90.4 SEK Current
2023-10-02 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 39 Quantity 78.8 SEK Current
2023-09-06 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 34 Quantity 86 SEK Current
2023-08-25 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 312 Quantity 89.732051 SEK Current
2023-07-18 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 96 Quantity 77.8 SEK Current
2023-07-14 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 210 Quantity 71.06 SEK Current
2023-07-14 Maria Ekdahl Chief Financial Officer (CFO) Acquisition Infant Bacterial Therapeutics AB ser. B Share · SE0008015259 210 Quantity 70.94 SEK Current
2023-06-29 Maria Ekdahl Chief Financial Officer (CFO) · Related person: Yes Subscription Infant Bacterial Ther. AB BTA B BTA · SE0020358232 277 Quantity 45 SEK Current
2023-06-29 Anthon Jahreskog Member of the Board of Directors Subscription Infant Bacterial Ther. AB BTA B BTA · SE0020358232 640 Quantity 45 SEK Current
2023-06-29 Staffan Strömberg Chief Executive Officer (CEO)/Managing Directory Subscription Infant Bacterial Ther. AB BTA B BTA · SE0020358232 17817 Quantity 45 SEK Current
2023-06-29 Anders Kronström Other senior executive Subscription Infant Bacterial Ther. AB BTA B BTA · SE0020358232 1899 Quantity 45 SEK Current
2023-06-29 Maria Ekdahl Chief Financial Officer (CFO) Subscription Infant Bacterial Ther. AB BTA B BTA · SE0020358232 284 Quantity 45 SEK Current

3748 publication days captured; dates between 2016-07-03 and 2026-10-08 may contain gaps. Checked 2026-10-09 11:01 UTC.

Showing 1–50 of 118 transactions